SCHEMBL4575759

SCHEMBL4575759

CN(C)CC(=Cc1ccccc1)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.58
CYP2C9 P11712 1/20 0.58
RECQL P46063 1/20 0.51
AKR1C3 P42330 1/20 0.50
AKR1C1 Q04828 1/20 0.44
ALDH1A1 P00352 3/20 0.43
EGFR P00533 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
KDM4E B2RXH2 1/20 0.43
USP2 O75604 1/20 0.43
HTT P42858 1/20 0.42
NPC1 O15118 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MME P08473 2/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 2/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31152626 0.83 RECQL (0.50) CYP3A4CYP2C9RECQLAKR1C3KMT2A
SCHEMBL9354507 0.82 CYP3A4 (0.54) CYP3A4CYP2C9RECQLAKR1C3AKR1C1
SCHEMBL9354466 0.81 CYP3A4 (0.53) CYP3A4CYP2C9RECQLAKR1C3ALDH1A1
SCHEMBL57683 0.79 CYP3A4 (0.63) CYP3A4CYP2C9RECQLAKR1C3AKR1C1
SCHEMBL2918640 0.79 CYP3A4 (0.63) CYP3A4CYP2C9RECQLAKR1C3AKR1C1
SCHEMBL309762 0.79 CYP3A4 (0.63) CYP3A4CYP2C9RECQLAKR1C3AKR1C1
SCHEMBL524131 0.76 ALOX5 (0.59) CYP3A4CYP2C9RECQLAKR1C3KMT2A
SCHEMBL8702152 0.76 ALOX5 (0.59) CYP3A4CYP2C9RECQLAKR1C3KMT2A
SCHEMBL1786246 0.76 ALOX5 (0.59) CYP3A4CYP2C9RECQLAKR1C3KMT2A
SCHEMBL9504328 0.76 RECQL (0.59) CYP3A4CYP2C9RECQLAKR1C3AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008039087-A2 INDOLINE DERIVATIVES AND USES THEREOF AUCKLAND UNISERVICES LIMITED (NZ) 2008-04-03 WO disclosed